Alexion Pharmaceuticals (ALXN) is a world-renowned biotechnology company founded in 1992 and headquartered in Connecticut, USA. In 2007, the company launched Soliris, the world's first drug for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), which has helped the company achieve great success.